SS-31

• 10mg lyophilized peptide

• Mitochondrial protection and antioxidant effects through selective binding to cardiolipin, a key mitochondrial phospholipid, which stabilizes mitochondrial membranes and reduces oxidative damage.
• Cellular longevity and energy optimization by supporting ATP production, improving mitochondrial efficiency, and helping mitigate mitochondrial dysfunction in high-energy-demand tissues like the heart, brain, and skeletal muscle.

SS-31 is frequently studied for

• Anti-aging and longevity support through improved mitochondrial resilience, helping slow age-related cellular decline and supporting tissue regeneration signals.
• Cardiovascular health support through protection of cardiac tissue and reductions in ischemia-reperfusion injury signals, with research interest in improving heart function in models relevant to heart failure and myocardial infarction.
• Neuroprotection and cognitive support through potential reductions in neurodegeneration signals, with research interest in models relevant to Alzheimer’s, Parkinson’s, and other neurological disorders.

• No major systemic adverse events reported in controlled preclinical testing

Researchers commonly explore SS-31 alongside other compounds depending on the study focus

• Anti-aging synergy: Crystagen, Epithalon, GHK-Cu (including blends like GLOW or KLOW), Humanin, Methylene Blue, MOTS-c, NAD+, SS-31
• Mitochondrial / energy-support models: MOTS-c, 5-Amino-1MQ, NAD+, Methylene Blue
• Neuroprotective pathways: Methylene Blue, Cerebroprotein Hydrolysate (Cerebrolysin), NAD+, Dihexa, MOTS-c, Semax, Selank, FGL, DNSP-11, Humanin